Home › Johnson & Johnson: Rewarding Patient, Deep Analysis Oriented Investors
 

Keywords :   


Johnson & Johnson: Rewarding Patient, Deep Analysis Oriented Investors

2015-10-21 21:10:12| Biotech - Topix.net

Johnson & Johnson, showing it's awareness from a shareholder sentiment standpoint, has approved a $10 billion share buyback program to reward patient and smart investors. I think if you can trust any company currently trading to navigate tough waters while also justifying investor patience and trust it's this one.

Tags: analysis deep johnson patient

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
17.05More people seek help for debts as fee scrapped
17.05Hunt hints at another National Insurance tax cut
17.05Alan Bates rejects second Post Office compensation offer
17.05Severn Trent boss defends multi-million pay packet
17.05Coptis Marks 25th Anniversary
17.05Farm Progress America, May 17, 2024
17.05Farm Progress America, May 17, 2024
17.05China pours billions into crisis-hit property market
More »